Optimal design of a population pharmacodynamic experiment for ivabradine (Q43597084)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Optimal design of a population pharmacodynamic experiment for ivabradine	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

title

Optimal design of a population pharmacodynamic experiment for ivabradine (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

main subject

pharmacodynamics

1 reference

based on heuristic

inferred from title

author

Stephen Duffull

series ordinal

1

object named as

S B Duffull

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

author name string

F Mentré

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

L Aarons

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

publication date

1 January 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

published in

Pharmaceutical Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

page(s)

83-89

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

cites work

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpretation of simulation studies for efficient estimation of population pharmacokinetic parameters.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacokinetic simulation model for ivabradine in healthy volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incorporating prior parameter uncertainty in the design of sampling schedules for pharmacokinetic parameter estimation experiments

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implementation of OSPOP, an algorithm for the estimation of optimal sampling times in pharmacokinetics by the ED, EID and API criteria.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal sampling times for pharmacokinetic experiments

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11336357

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1023/A:1011035028755

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

PubMed publication ID

11336357

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11336357

retrieved

25 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43597084&oldid=2143945954"